Halbert Hargrove Global Advisors’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$1.61M Sell
1,746
-54
-3% -$54.7K 0.08% 40
2025
Q4
$1.93M Sell
1,800
-45
-2% -$43K 0.09% 34
2025
Q3
$1.41M Sell
1,845
-3
-0.2% -$2.23K 0.07% 42
2025
Q2
$1.44M Sell
1,848
-28
-1% -$21.8K 0.08% 38
2025
Q1
$1.55M Buy
1,876
+28
+2% +$23.3K 0.09% 35
2024
Q4
$1.43M Sell
1,848
-290
-14% -$240K 0.08% 37
2024
Q3
$1.89M Hold
2,138
0.1% 33
2024
Q2
$1.94M Sell
2,138
-55
-3% -$44K 0.11% 32
2024
Q1
$1.71M Buy
2,193
+11
+0.5% +$7.83K 0.11% 36
2023
Q4
$1.27M Buy
2,182
+8
+0.4% +$4.67K 0.09% 40
2023
Q3
$1.17M Sell
2,174
-22
-1% -$11.3K 0.09% 39
2023
Q2
$1.03M Sell
2,196
-1,238
-36% -$519K 0.08% 38
2023
Q1
$1.18M Sell
3,434
-562
-14% -$190K 0.08% 44
2022
Q4
$1.46M Buy
3,996
+90
+2% +$31.9K 0.1% 37
2022
Q3
$1.26M Buy
3,906
+13
+0.3% +$4.12K 0.1% 41
2022
Q2
$1.26M Buy
3,893
+2,266
+139% +$680K 0.09% 40
2022
Q1
$466K Buy
1,627
+33
+2% +$8.49K 0.03% 80
2021
Q4
$440K Buy
1,594
+5
+0.3% +$1.27K 0.03% 84
2021
Q3
$367K Sell
1,589
-16
-1% -$3.95K 0.03% 83
2021
Q2
$368K Hold
1,605
0.02% 89
2021
Q1
$300K Sell
1,605
-86
-5% -$16.8K 0.02% 90
2020
Q4
$285K Sell
1,691
-17
-1% -$2.54K 0.02% 84
2020
Q3
$253K Sell
1,708
-5
-0.3% -$774 0.02% 79
2020
Q2
$281K Buy
1,713
+92
+6% +$14.1K 0.04% 66
2020
Q1
$225K Sell
1,621
-22
-1% -$3.02K 0.04% 70
2019
Q4
$216K Buy
+1,643
New +$190K 0.06% 77
2015
Q3
Sell
-2,920
Closed -$244K 140
2015
Q2
$244K Buy
2,920
+42
+1% +$3.2K 0.06% 159
2015
Q1
$209K Buy
+2,878
New +$205K 0.07% 174

Other funds holding LLY

Halbert Hargrove Global Advisors's LLY Position: Q1 2026 in Review

Halbert Hargrove Global Advisors reduced its Eli Lilly (LLY) stake by 3% in Q1 2026, selling an estimated $54.7K and leaving 1,746 shares worth $1.61M. The position accounts for 0.08% of the portfolio, ranked #40.

Halbert Hargrove Global Advisors first reported a position in LLY in Q1 2015 and has held it in 28 quarters since. The position peaked at $1.94M in Q2 2024. 4,351 funds tracked by Wall St. Rank hold LLY as of Q1 2026.

  • Halbert Hargrove Global Advisors held 1,746 shares of Eli Lilly worth $1.61M as of Q1 2026.
  • Halbert Hargrove Global Advisors sold 54 Eli Lilly shares in Q1 2026, an estimated $54.7K.
  • Eli Lilly made up 0.08% of Halbert Hargrove Global Advisors's portfolio in Q1 2026, its #40 holding.
  • Halbert Hargrove Global Advisors first reported a position in Eli Lilly in Q1 2015 and has held it in 28 quarters since.
  • Halbert Hargrove Global Advisors's Eli Lilly position peaked at $1.94M in Q2 2024.
  • 4,351 funds tracked by Wall St. Rank held Eli Lilly as of Q1 2026.

Based on Halbert Hargrove Global Advisors's 13F filing for Q1 2026, filed 17 Apr 2026.